This wiki has undergone a migration to Confluence found Here
Difference between revisions of "20181116 PLA call"
Jump to navigation
Jump to search
(→Agenda) |
|||
| Line 77: | Line 77: | ||
===Agenda=== | ===Agenda=== | ||
Agenda review | Agenda review | ||
| − | *Notes of [[ | + | *Notes of [[20181102_PLA_call]] review |
*Discussion | *Discussion | ||
**Who would be responsible for steering division responsibilities if they went away | **Who would be responsible for steering division responsibilities if they went away | ||
Revision as of 16:35, 16 November 2018
return to HL7 Product Line Architecture Meeting Minutes and Agendas
Return to HL7 Product Line Architecture Program
| HL7 PLA Call Minutes Location: Phone: +1 770-657-9270, Participant Code: 985371, |
Date: 2017-11-16 Time: 11:30 AM | ||
| Facilitator | Mary Kay/ Austin | Note taker(s) | Anne |
| Attendee | Name
| ||
| Calvin Beebe | |||
| Lorraine Constable | |||
| Jean Duteau, | |||
| Tony Julian | |||
| Paul Knapp | |||
| Austin Kreisler, | |||
| Mary Kay McDaniel | |||
| Brian Pech | |||
| Wayne Kubick | |||
| John Roberts | |||
| Andy Stechishin | |||
| no quorum definition | |||
Agenda
Agenda review
- Notes of 20181102_PLA_call review
- Discussion
- Who would be responsible for steering division responsibilities if they went away
- Catch-all product family
- Where do roles of a management group reside when there is a lack of a management group
- Management group health metrics
- notional division of products into product families and lines, to provide examples for peer review.
- Level of granularity
- Identify which pieces are orphaned, and the political elements to be surfaced.
- Positioning cross-product family artifacts (standards naming)
- BAM-lite feedback and review
- Governance on V2.x (v2.9 substantive changes)
- develop form to request establishing a Product Family
Minutes
Convened
Adjourned
Meeting Outcomes
| Actions
|
| Next Meeting/Preliminary Agenda Items |
© 2018 Health Level Seven® International. All rights reserved
